Koninklijke Philips N.V.

PHG Healthcare Medical Devices

Koninklijke Philips N.V.’s revenue for fiscal 2025 (year ended December 2025) was $20.2 billion, up 3.47% from fiscal 2024.

Revenue
+0.55%
EPS
−85.0%
Free cash flow
+154.2%
Total debt
−4.96%

Quarter to September 2026, against a year earlier

30.29 0.22 −0.72%
Market cap
$29.8B
P/E
25.8×
Fwd P/E
11.2×
Dividend yield
3.33%
F-score
7/9
Altman Z
1.98
Beneish M
−2.68
Dividend safety
55/100
Older periods Dec '25 Mar '26 Jun '26 Sep '26
Piotroski F-Score

+8 more TTM periods

— — 7 —
ROE
8.02% 8.63% 10.20% 8.54%
ROA
3.25% 3.67% 4.21% 3.49%
ROIC
5.91% 5.91% 6.69% 6.15%
Return on Tangible Assets
19.29% 20.90% 27.07% 19.89%
Average Days of Receivables
73.47 69.14 74.19 73.73
Free Cash Flow per Share
0.61 1.85 1.94 2.17
Free Cash Flow
580.41 1,763.60 1,849.65 2,116.65
Other line items

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026